[{"AccountsPayableCurrent_0_Q1_USD":18707000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear_0_Q1_security":92.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":439528000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":524031000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":523965000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":1454000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":1520000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":19690000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":74000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-126000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":10500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":58.2,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":6749373.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7006000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":19690000.0,"IncreaseDecreaseInContractWithCustomerAsset_1_Q1_USD":2861000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":11813000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":167501000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":89093000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":84503000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":224000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-128000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":1009000.0,"InvestmentIncomeInterest_1_Q1_USD":2936000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":571000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-128000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":613100000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":8162000.0,"ContractWithCustomerAssetNet_0_Q1_USD":11813000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":4748000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":5465000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":54911000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.057,"OperatingLeaseRightOfUseAsset_0_Q1_USD":91440000.0,"OperatingLeasePayments_1_Q1_USD":3900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":104010000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":6466000.0,"OperatingLeaseLiability_0_Q1_USD":110476000.0,"OperatingLeaseCost_1_Q1_USD":3800000.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":30750000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":9395000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-40384000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":14380000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":18126000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":18660000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":141226000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":8589000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":180000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-14967000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":881000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":80000.0,"DeferredRentCreditCurrent_0_Q1_USD":306000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":0.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":59248000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":16773000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q1_USD":0.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2181517000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4726000.0,"StockholdersEquity_0_Q1_USD":625299000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1556361000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":33840000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":29152000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":4455000.0,"NetIncomeLoss_1_Q1_USD":-40256000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-105358000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":108135000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":5385000.0,"LiabilitiesCurrent_0_Q1_USD":69858000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":799738000.0,"Liabilities_0_Q1_USD":174439000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":68608279.0,"InventoryNet_0_Q1_USD":9778000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2009000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":38501000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.59,"Depreciation_1_Q1_USD":2474000.0,"CostsAndExpenses_1_Q1_USD":130290000.0,"CommonStockValue_0_Q1_USD":69000.0,"CommonStockSharesOutstanding_0_Q1_shares":68789925.0,"CommonStockSharesIssued_0_Q1_shares":68789925.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":89093000.0,"AssetsCurrent_0_Q1_USD":587274000.0,"Assets_0_Q1_USD":799738000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8132598.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":6774000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":87098000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":39631000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":69.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":792048.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":110904.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":59.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":3874135.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":1800000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":533000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":5444000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":51.09,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":25.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":58.2,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":6749373.0,"IncreaseDecreaseInInventories_1_Q1_USD":2447000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":707000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":5465000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":133256.0,"ShareBasedCompensation_1_Q1_USD":19690000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":91256000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":25000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-43192000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":9238000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"Ticker":"AGIO","CIK":"1439222","name":"AGIOS PHARMACEUTICALS, INC.","OfficialName":"Agios Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1422760526.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200430"}]